Rheumnow Podcast cover image

EULAR 2023 Lupus Highlights

Rheumnow Podcast

00:00

Jack Inhibitors: A Possible Blockbuster

Upada-Sydnib, 15 milligrams a day, an act of non-renal lupus was in an RCT. The outcome measurements were positive for Upah plus BTK trial. Barisydnib four milligram a day versus cyclophosomide and active renal lupus nephritis. And follow me more for more content on my Twitter handle, Bella and Desko Mehta.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app